维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="PLATZBECKER U"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Chelerythrin activates caspase-8,downregulates FLIP long and short,and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells显示文摘	Platzbecker U Ward JL Deeg HJ	2003	Br J Haematol2003，122，3：	1
2	Update on de,elop- ments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS) : consensus statements and report from an expert workshop 显示文摘	Platzbecker U Santini V Mufti GJ	2012	Leuk Res2012，36，3：	1
3	P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
4	Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation显示文摘	Schroeder T Czibere A Platzbecker U	2013	Leukemia2013，27，6：	1
5	Allogeneic trans, plantation of CD34^+ selected hematopoietic cells-clinical problems and current challenges 显示文摘	Platzbecker U Ehninger G Bomhauser M	2004	Leuk Lymphoma2004，45，3：	1
6	The clinical,quality of life,and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes显示文摘	Platzbecker U Hofbauer LC Ehninger G		0，，05：	1
7	Phase 2 study of oral panobinostat (LBH589) with or without eryth- ropoietin in heavily transfusion-dependent IPSS low or int- 1 MDS patients显示文摘	Platzbecker U A1-Ali H K Gattermann N	2014	Leukemia2014，28，3：	1
8	P-glycoprotein-rnediated dr- ug effiux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate 显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
9	Azacitidine for treatment of patients with myelodysplastic syndromes (MDS):practical recommendations of the German MDS Study Group显示文摘	G?tze K Platzbecker U Giagounidis A		0，，09：	1
10	Stem cell transplantation for patients with Evans syndrome显示文摘	Benesch M Urban C Platzbecker U et a1	2009	Expert Rev Clin Immunol2009，5，3：	1
11	P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
12	Who benefits from allogeneic transplantation for myelodysplastic syndromes: new insights 显示文摘	Platzbecker U	2013	Hematology Am Soc Hematol Educ Program2013，2013，：	1
13	Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneie HSCT:results of the RELAZA trial显示文摘	Platzbecker U Wermke M Radke J	2012	Leukemia2012，26，3：	1
14	Activity of sirolimus in patients with myelodysplastic syndrome: results of a pilot study 显示文摘	Platzbecker U Haase M Herbst R	2005	Br J Haematol2005，128，5：	1
15	Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial 显示文摘	Platzbecker U Wennke M Radke J	2012	Leukemia2012，26，3：	1
16	Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation 显示文摘	Schroeder T Czibere A Platzbecker U	2013	Leukemia2013，27，6：	1
17	Sequential combination of azacitidine and lenalidomide in del (5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia:a phase Ⅰ study显示文摘	Platzbecker U Braulke F Kündgen A	2013	Leukemia2013，27，6：	1
18	Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin 显示文摘	Platzbecker U Klinge K Thiedel C	2001	Bone Marrow Transplantation2001，27，1：	1
19	P-glycoprmeinmediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate 显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1
20	P-glycoprotein mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate显示文摘	Illmer T Schaich M Platzbecker U	2004	Leukemia2004，18，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示